Chicago, Oct. 19, 2022 (GLOBE NEWSWIRE) — According to the new market research report “Clinical Trial Imaging Market by software and services (operational imaging, read analysis), modality (CT, MRI, X-ray, PET, ultrasound, ECHO), therapeutic areas (infectious, oncology, CNS, CVS), end user (pharmaceutical, biotechnology, CRO) – Global Forecast to 2026″, is expected to reach USD 1.4 billion by 2026, from USD 1.0 billion in 2021, with a CAGR of 7.6%.
Browse and deepen the table of contents on “Clinical Trial Imaging Market”
198- Tables
38- Numbers
206- Pages
Download the PDF brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=30446624
Scope of Clinical Trial Imaging Market:
| Report metric | Details |
| Market size | $1.4 billion by 2026 |
| CAGR | 7.6% |
| Historical data | 2019-2020 |
| Year of reference | 2020 |
| Forecast period | 2021-2026 |
| Forecast units | Value (USD billion) |
| Report cover | Revenue forecasts, competitive landscape, growth factors and trends |
| Segments Covered | By product and service, By modality, By therapeutic area, By end user, By geography |
| Geographical areas covered | North America, Europe, Asia-Pacific, LAME and Rest of the World |
| Top Profiled Companies/Suppliers | ICON plc. (Ireland) | BioTelemetry Inc. (USA) | Biomedical Systems Corporation (USA) | Medspace Holdings | Inc. (USA) | IXICO plc. (United Kingdom) | Resonance Health Ltd. (Australia) | Radiant Sage LLC. (United States) | BioClinica Inc. (USA) | Intrinsic Imaging LLC. (United States) | Cardiovascular Imaging Technologies LLC. (United States) | Medical Metrics Inc. (USA) | Prism Clinical Imaging | Inc. (USA) | Boston Imaging Core Lab LLC. (United States) | anagram 4 clinical trials (Spain) | Medical imaging company Lyscaut (Belgium) | Calyx Group (UK) | Bioseptive Inc. (Canada) | ProScan Imaging LLC. (United States) | Micron Inc. (Japan) | LI Imaging Endpoints | LLC (USA) | Perspective Ltd. (United Kingdom) | Pharmtrace klinische Entwicklung GmbH (Germany) | WorldCare Clinical LLC (USA). |
| Key market opportunities | Developing countries |
| Key Market Drivers | Driver: Increased R&D spending |
Growing number of CROs, increasing R&D expenditures, growing pharmaceutical and biotech market are the major factors driving the growth of the market.
Based on products and services, the clinical trial imaging market is segmented into services and software. In 2020, the software segment accounted for the largest share of the market, mainly due to the increase in R&D expenditures and the growth of pharmaceutical and biotechnology industries.
Based on modality, clinical trial imaging market is segmented into computed tomography, magnetic resonance imaging, ultrasound, positron emission tomography, x-ray, echocardiography and other modalities. In 2020, the CT segment accounted for the largest market share. The large share of this segment can be mainly attributed to the growing number of CROs and increasing R&D expenditures.
Request sample pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=30446624
Based on therapeutic area, the clinical trial imaging market has been segmented into oncology, infectious diseases, neurology, CVS, endocrinology, immunological disorders and another therapeutic area. In 2020, the oncology segment accounted for the largest share of the market, primarily due to increasing R&D spending and growth in pharmaceutical and biotechnology industries.
Based on end users, the clinical trial imaging market has been segmented into pharmaceutical companies, biotechnology companies, medical device manufacturers, contract research organizations, academic and government research institutes, and other end users. In 2020, the pharmaceutical companies segment accounted for the largest share of the market, mainly due to the growing number of CROs and the growth of pharmaceutical and biotechnology industries.
Talk to the analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=30446624
Geographic growth scenario:
The global clinical trial imaging market is segmented into five major regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America accounted for the largest regional market for the market in 2020. North America’s large share in this market can be attributed to the growing number of CROs, growth in pharmaceutical and biotechnology industries, and the increase in R&D expenditure.
Key players:
The major players operating in this clinical trial imaging market are ICON plc. (Ireland), BioTelemetry Inc. (USA), Biomedical Systems Corporation (USA), Medpace Holdings, Inc. (USA), IXICO plc. (UK), Resonance Health Ltd. (Australia), Radiant Sage LLC. (USA), BioClinica Inc. (USA), Intrinsic Imaging LLC. (USA), Cardiovascular Imaging Technologies LLC. (USA), Medical Metrics Inc. (USA), Prism Clinical Imaging, Inc. (USA), Boston Imaging Core Lab LLC. (USA), Anagram 4 Clinical Trials (Spain), Lyscaut Medical Imaging Company (Belgium), Calyx Group (UK), Bioseptive Inc. (Canada), ProScan Imaging LLC. (USA), Micron Inc. (Japan), Imaging Endpoints LI, LLC (USA), Perspectum Ltd. (UK), Pharmtrace klinische Entwicklung GmbH (Germany), WorldCare Clinical, LLC (USA).
Browse adjacent markets @ Medical Devices Market Research reports and advice
Browse related reports:
diagnostic imaging market – Global forecasts until 2026
Contract Research Organization (CRO) Services Market – Global forecasts until 2027
clinical trial supplies market – Global Forecast 2026
eClinical Solutions Market – Global forecasts until 2026
Clinical Trial Management System/CTMS Market – Global forecasts until 2025
.